Azmi Nabulsi, Chief Operating Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 26,300 shares at $38.09 ($1.0M) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $1.0M PHAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.09 | 5,416 | $206K | 19.7% |
| 2 | $38.09 | 5,416 | $206K | 19.7% |
| 3 | $40.51 | 2,700 | $109K | 10.4% |
| 4 | $41.16 | 6,384 | $263K | 25.1% |
| 5 | $41.16 | 6,384 | $263K | 25.1% |
| Total | $39.83 avg | 26,300 |
| $1.0M |
| 100% |
| Filing → |
| PHAT | SELL | 2024-07-17 | $256K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $83K | — | Filing → |
| PHAT | BUY | 2022-05-16 | $163K | — | Filing → |